143 related articles for article (PubMed ID: 34694152)
1. Postchemotherapy Residual Tumor Resection in Patients with Elevated Tumor Markers.
Che Y; Buddensieck C; Albers P; Lusch A; Winter C; Siemer RG; Hiester A
J Urol; 2022 Mar; 207(3):617-626. PubMed ID: 34694152
[TBL] [Abstract][Full Text] [Related]
2. [In which marker-positive patients with germ cell tumors is residual tumor resection of value?].
Weinknecht S; Hartmann M; Weissbach L
Urologe A; 1998 Nov; 37(6):621-4. PubMed ID: 9887490
[TBL] [Abstract][Full Text] [Related]
3. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
Kobayashi T; Kawakita M; Terachi T; Habuchi T; Ogawa O; Kamoto T
J Surg Oncol; 2006 Dec; 94(7):619-23. PubMed ID: 17111392
[TBL] [Abstract][Full Text] [Related]
4. Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.
Wood DP; Herr HW; Motzer RJ; Reuter V; Sogani PC; Morse MJ; Bosl GJ
Cancer; 1992 Nov; 70(9):2354-7. PubMed ID: 1382832
[TBL] [Abstract][Full Text] [Related]
5. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
[TBL] [Abstract][Full Text] [Related]
6. Retroperitoneal lymph node dissection in the setting of elevated markers.
Lakes J; Lusch A; Nini A; Albers P
Curr Opin Urol; 2018 Sep; 28(5):435-439. PubMed ID: 30004909
[TBL] [Abstract][Full Text] [Related]
7. Correlation of serum tumor markers in advanced germ cell tumors with responses to chemotherapy and surgery.
Vugrin D; Friedman A; Whitmore WF
Cancer; 1984 Mar; 53(6):1440-5. PubMed ID: 6198071
[TBL] [Abstract][Full Text] [Related]
8. Postchemotherapy Resection of Residual Mass in Nonseminomatous Germ Cell Tumor.
Ghodoussipour S; Daneshmand S
Urol Clin North Am; 2019 Aug; 46(3):389-398. PubMed ID: 31277733
[TBL] [Abstract][Full Text] [Related]
9. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
10. [Postchemotherapy residual tumour resection in complex metastatic sites of advanced testicular germ cell tumours].
Paffenholz P; Pfister D; Heidenreich A
Urologe A; 2016 May; 55(5):632-40. PubMed ID: 26820659
[TBL] [Abstract][Full Text] [Related]
11. Postchemotherapy retroperitoneal lymph node dissection in patients presenting with very high HCG levels.
Speir RW; Calaway AC; Einhorn LH; Foster RS; Cary C
Urol Oncol; 2020 Aug; 38(8):687.e19-687.e23. PubMed ID: 32448503
[TBL] [Abstract][Full Text] [Related]
12. Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum.
Vuky J; Bains M; Bacik J; Higgins G; Bajorin DF; Mazumdar M; Bosl GJ; Motzer RJ
J Clin Oncol; 2001 Feb; 19(3):682-8. PubMed ID: 11157018
[TBL] [Abstract][Full Text] [Related]
13. Postchemotherapy residual masses in germ cell tumor patients: our experience.
Morelli F; Tozzi L; Setola P; Bisceglia M; Barbini VR; Maiello E
Ann Oncol; 2006 Jun; 17 Suppl 7():vii132-6. PubMed ID: 16760276
[TBL] [Abstract][Full Text] [Related]
14. Outcome of patients with residual germ cell or non-germ cell malignancy after resection of primary mediastinal nonseminomatous germ cell cancer.
Schneider BP; Kesler KA; Brooks JA; Yiannoutsos C; Einhorn LH
J Clin Oncol; 2004 Apr; 22(7):1195-200. PubMed ID: 15051766
[TBL] [Abstract][Full Text] [Related]
15. [High-dose chemotherapy and residual tumor resection in male germ cell tumors].
Lorch A; Albers P; Winter C; Beyer J
Urologe A; 2011 Sep; 50(9):1047-54. PubMed ID: 21845425
[TBL] [Abstract][Full Text] [Related]
16. Postchemotherapy resections of residual masses from metastatic non-seminomatous testicular germ cell tumors.
Hartmann JT; Schmoll HJ; Kuczyk MA; Candelaria M; Bokemeyer C
Ann Oncol; 1997 Jun; 8(6):531-8. PubMed ID: 9261521
[TBL] [Abstract][Full Text] [Related]
17. Logarithmic decrease of serum alpha-fetoprotein or human chorionic gonadotropin in response to chemotherapy can distinguish a subgroup with better prognosis among highly malignant intracranial non-germinomatous germ cell tumors.
Kawaguchi T; Kumabe T; Kanamori M; Saito R; Yamashita Y; Sonoda Y; Watanabe M; Tominaga T
J Neurooncol; 2011 Sep; 104(3):779-87. PubMed ID: 21359564
[TBL] [Abstract][Full Text] [Related]
18. Late relapsing germ cell tumors with elevated tumor markers.
Che Y; Lusch A; Winter C; Große Siemer R; Buddensieck C; Albers P; Hiester A
World J Urol; 2022 Feb; 40(2):363-371. PubMed ID: 34518930
[TBL] [Abstract][Full Text] [Related]
19. [The role of salvage surgery following chemotherapy in advanced testicular cancer].
Miki T; Saki S; Kotake T
Hinyokika Kiyo; 1994 Oct; 40(10):951-5. PubMed ID: 7992713
[TBL] [Abstract][Full Text] [Related]
20. Resection of primary mediastinal non-seminomatous germ cell tumors: a 28-year experience at memorial sloan-kettering cancer center.
Sarkaria IS; Bains MS; Sood S; Sima CS; Reuter VE; Flores RM; Motzer RJ; Bosl GJ; Rusch VW
J Thorac Oncol; 2011 Jul; 6(7):1236-41. PubMed ID: 21610519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
